(Q38942116)

7 September 2017

title

Interaction between NADPH-oxidase and Rho-kinase in angiotensin II-induced microglial activation (English)

1 reference

Ana Isabel Rodriguez Perez

7 September 2017

1 reference

series ordinal

1

object named as

Ana I Rodriguez-Perez

1 reference

7 September 2017

2

Ana Borrajo

1 reference

Jannette Rodriguez-Pallares

7 September 2017

series ordinal

3

object named as

Jannette Rodriguez-Pallares

1 reference

7 September 2017

4

Maria J Guerra

1 reference

7 September 2017

Jose L Labandeira-Garcia

series ordinal

5

object named as

Jose L Labandeira-Garcia

1 reference

7 September 2017

language of work or name

1 reference

6 November 2014

1 reference

7 September 2017

1 reference

7 September 2017

volume

63

1 reference

7 September 2017

issue

3

1 reference

7 September 2017

page(s)

466-482

1 reference

ROCK/Cdc42-mediated microglial motility and gliapse formation lead to phagocytosis of degenerating dopaminergic neurons in vivo.

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

Lysophosphatidic acid receptor activation affects the C13NJ microglia cell line proteome leading to alterations in glycolysis, motility, and cytoskeletal architecture

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

Inhibition of the microglial response is essential for the neuroprotective effects of Rho-kinase inhibitors on MPTP-induced dopaminergic cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

Microglial TNF-α mediates enhancement of dopaminergic degeneration by brain angiotensin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

Targeting Rho and Rho-kinase in the treatment of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

RhoA and p38 MAPK mediate apoptosis induced by cellular cholesterol depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

Fasudil and its analogs: a new powerful weapon in the long war against central nervous system disorders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

Characterization of phenotype markers and neuronotoxic potential of polarised primary microglia in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

NADPH oxidase 1-mediated oxidative stress leads to dopamine neuron death in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

Inhibition of NADPH oxidase promotes alternative and anti-inflammatory microglial activation during neuroinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

Origin of the angiotensin II secreted by cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

Brain angiotensin regulates iron homeostasis in dopaminergic neurons and microglial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

Expression of angiotensinogen and receptors for angiotensin and prorenin in the monkey and human substantia nigra: an intracellular renin-angiotensin system in the nigra

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

Anti-inflammatory and neuroprotective effects of an orally active apocynin derivative in pre-clinical models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

Introduction to NF-kappaB: players, pathways, perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

Vulnerability of mesostriatal dopaminergic neurons in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

Angiotensin type 1 receptor antagonist losartan, reduces MPTP-induced degeneration of dopaminergic neurons in substantia nigra.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

NAD(P)H oxidase: role in cardiovascular biology and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

Neutrophil nicotinamide adenine dinucleotide phosphate oxidase assembly. Translocation of p47-phox and p67-phox requires interaction between p47-phox and cytochrome b558.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

Long-term inhibition of Rho-kinase suppresses angiotensin II-induced cardiovascular hypertrophy in rats in vivo: effect on endothelial NAD(P)H oxidase system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

Inflammatory stimuli upregulate Rho-kinase in human coronary vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

Neuroinflammation in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

Atorvastatin protects against cerebral infarction via inhibition of NADPH oxidase-derived superoxide in ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

The inflammatory response in the MPTP model of Parkinson's disease is mediated by brain angiotensin: relevance to progression of the disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

Dopamine-angiotensin interactions in the basal ganglia and their relevance for Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

Mechanism of endothelial cell NADPH oxidase activation by angiotensin II. Role of the p47phox subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

Apocynin improves erectile function in diabetic rats through regulation of NADPH oxidase expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

Microglial activation and chronic neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

Live longer sans the AT1A receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

Rho kinase, a promising drug target for neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

Reduction of dopaminergic degeneration and oxidative stress by inhibition of angiotensin converting enzyme in a MPTP model of parkinsonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

ROCK-I and ROCK-II, two isoforms of Rho-associated coiled-coil forming protein serine/threonine kinase in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

Angiotensin II signal transduction through small GTP-binding proteins: mechanism and significance in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

Applications for ROCK kinase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

Angiotensin II stimulates MCP-1 production in rat glomerular endothelial cells via NAD(P)H oxidase-dependent nuclear factor-kappa B signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

Oxidative stress and microglial cells in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

Oral treatment with the NADPH oxidase antagonist apocynin mitigates clinical and pathological features of parkinsonism in the MPTP marmoset model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

NADPH oxidase and aging drive microglial activation, oxidative stress, and dopaminergic neurodegeneration following systemic LPS administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

NADPH oxidase mediates lipopolysaccharide-induced neurotoxicity and proinflammatory gene expression in activated microglia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

NADPH oxidase and endothelial cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

Tissue renin angiotensin systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

Angiotensin type-1-receptor antagonists reduce 6-hydroxydopamine toxicity for dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

Monokine production by microglial cell clones

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

Mitochondrial ATP-sensitive potassium channels enhance angiotensin-induced oxidative damage and dopaminergic neuron degeneration. Relevance for aging-associated susceptibility to Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

Brain angiotensin enhances dopaminergic cell death via microglial activation and NADPH-derived ROS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

Dopaminergic degeneration is enhanced by chronic brain hypoperfusion and inhibited by angiotensin receptor blockage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

Inhibition of Rho kinase mediates the neuroprotective effects of estrogen in the MPTP model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

Redox control of microglial function: molecular mechanisms and functional significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

Dose-dependent regulation of NAD(P)H oxidase expression by angiotensin II in human endothelial cells: protective effect of angiotensin II type 1 receptor blockade in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

Statins suppress oxidized low density lipoprotein-induced macrophage proliferation by inactivation of the small G protein-p38 MAPK pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

Lysophosphatidylcholine induces glial cell activation: role of rho kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

Rho kinase inhibitor fasudil protects against β-amyloid-induced hippocampal neurodegeneration in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

Inhibition of rho kinase enhances survival of dopaminergic neurons and attenuates axonal loss in a mouse model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

Rho kinase inhibition modulates microglia activation and improves survival in a model of amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

p38 Mitogen-activated protein kinase and extracellular signal-regulated kinase signaling pathways are not essential regulators of formyl peptide-stimulated p47(phox) activation in neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

Involvement of microglial RhoA/Rho-kinase pathway activation in the dopaminergic neuron death. Role of angiotensin via angiotensin type 1 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

Impaired CD200-CD200R-mediated microglia silencing enhances midbrain dopaminergic neurodegeneration: roles of aging, superoxide, NADPH oxidase, and p38 MAPK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

A Role for the Brain RAS in Alzheimer's and Parkinson's Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

Rho-kinase inhibitor, fasudil, prevents neuronal apoptosis via the Akt activation and PTEN inactivation in the ischemic penumbra of rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

Relationship between p38 mitogen-activated protein kinase and small GTPase Rac for the activation of NADPH oxidase in bovine neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

Nogo-66 inhibits adhesion and migration of microglia via GTPase Rho pathway in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

Generation of reactive oxygen species in 1-methyl-4-phenylpyridinium (MPP+) treated dopaminergic neurons occurs as an NADPH oxidase-dependent two-wave cascade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

Phenylalanine activates the mitochondria-mediated apoptosis through the RhoA/Rho-associated kinase pathway in cortical neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

7 January 2021

Lovastatin inhibits brain endothelial cell Rho-mediated lymphocyte migration and attenuates experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

7 January 2021

RhoA activation promotes transendothelial migration of monocytes via ROCK.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

7 January 2021

p160 RhoA-binding kinase ROKalpha induces neurite retraction

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

7 January 2021

Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

7 January 2021

Rho kinase inhibitor fasudil regulates microglia polarization and function

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22765

7 January 2021

Identifiers

DOI

10.1002/GLIA.22765

1 reference

7 September 2017

1 reference